Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-08

Clinical Trial Update: Lactoferrin or Progesterone for Prevention of Preterm Delivery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is investigating lactoferrin versus progesterone for the prevention of preterm birth; the update does not include results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactoferrin (lactoferrin)
  • PROGESTERONE (Progesterone)

Snippet

Sponsor: University of Padova | Conditions: Preterm Delivery | Phase 4 | Status: UNKNOWN